Today, the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.
FDA grants Enhertu tumor-agnostic accelerated approval
The FDA on Friday gave Daiichi Sankyo and AstraZeneca’s antibody-drug conjugate Enhertu a tumor-agnostic indication under accelerated approval. It’s the first such approval for a